Tracy Newbold

Chief Tech/Sci/R&D Officer at LEXICON PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Jeffrey Wade	M	59	LEXICON PHARMACEUTICALS, INC.	25 years
Samuel Barker	M	81	LEXICON PHARMACEUTICALS, INC.	24 years
Lonnel Coats	M	58	LEXICON PHARMACEUTICALS, INC.	10 years
James Edgemond	M	56	UNITED THERAPEUTICS CORPORATION	11 years
Michael Benkowitz	M	52	UNITED THERAPEUTICS CORPORATION	13 years
Ray Debbane	M	69	LEXICON PHARMACEUTICALS, INC.	17 years
Kenneth Kassler-Taub	M	-	LEXICON PHARMACEUTICALS, INC.	10 years
Brian Crum	M	51	LEXICON PHARMACEUTICALS, INC.	23 years
Katherine Klein	M	67	UNITED THERAPEUTICS CORPORATION	10 years
Judy Olian	M	72	UNITED THERAPEUTICS CORPORATION	9 years
Judith Swain	M	75	LEXICON PHARMACEUTICALS, INC.	17 years
Philippe Amouyal	M	65	LEXICON PHARMACEUTICALS, INC.	17 years
Christopher Sobecki	M	65	LEXICON PHARMACEUTICALS, INC.	17 years
Robert Lefkowitz	M	80	LEXICON PHARMACEUTICALS, INC.	23 years
Lisa M. DeFrancesco	F	45	LEXICON PHARMACEUTICALS, INC.	1 years
Craig Granowitz	M	60	LEXICON PHARMACEUTICALS, INC.	3 years
Diane Sullivan	F	62	LEXICON PHARMACEUTICALS, INC.	1 years
Kristen Alexander	F	56	LEXICON PHARMACEUTICALS, INC.	7 years
Wendy Mcdermott	F	-	LEXICON PHARMACEUTICALS, INC.	2 years
Tom Garner	M	-	LEXICON PHARMACEUTICALS, INC.	1 years

Multi-company connection

Name	Gender	Age	Linked companies	Collaboration
Roger Jeffs	M	62	UNITED THERAPEUTICS CORPORATION	18 years
John Maxim Ferrari	M	69	UNITED THERAPEUTICS CORPORATION	14 years
Frank Palantoni	M	66	LEXICON PHARMACEUTICALS, INC.	19 years
Alan Nies	M	86	LEXICON PHARMACEUTICALS, INC.	20 years
James F. Tessmer	M	64	LEXICON PHARMACEUTICALS, INC.	20 years
Chas Schultz	M	-	LEXICON PHARMACEUTICALS, INC.	-
Kiernan A. Seth	M	-	LEXICON PHARMACEUTICALS, INC.	9 years
David Zaccardelli	M	59	UNITED THERAPEUTICS CORPORATION	12 years
Martin Auster	M	49	UNITED THERAPEUTICS CORPORATION	5 years
Casper Breum	M	57	Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel.	4 years
Eugene Jeffrey Sullivan	M	59	UNITED THERAPEUTICS CORPORATION	5 years
Alexander Sapir	M	57	UNITED THERAPEUTICS CORPORATION	10 years
L. Smith	M	57	UNITED THERAPEUTICS CORPORATION	2 years
Scott Moomaw	M	54	UNITED THERAPEUTICS CORPORATION	5 years
Kiernan T. DeAngelis	M	54	UNITED THERAPEUTICS CORPORATION	4 years
Matthew Cullen	M	-	LEXICON PHARMACEUTICALS, INC.	1 years

Country	Connections	% of total
United States	35	97.22%
Israel	1	2.78%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections